Related articles
mRNA
Messenger RNA platform used in Moderna's personalized cancer vaccine and in some other candidate cancer vaccines.
- Experimental pancreatic cancer vaccine triggers an immune response in nearly 99% of patients
- Merck and Moderna’s mRNA cancer vaccine takes center stage in oncology podcast
- Cancer advances renew focus on patients’ quality of life
- Cancer Vaccines Advance: Moderna's Personalized mRNA Shows Promise at ESMO Congress in Madrid